1stDrugResearch ApS
Credit rating
Company information
About 1stDrugResearch ApS
1stDrugResearch ApS (CVR number: 40927697) is a company from SKANDERBORG. The company recorded a gross profit of -11.5 kDKK in 2020. The operating profit was -11.5 kDKK, while net earnings were -10.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -6.6 %, which can be considered poor and Return on Equity (ROE) was -9.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 73.9 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. 1stDrugResearch ApS's liquidity measured by quick ratio was 3.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | |
---|---|---|
Volume | ||
Net sales | ||
Gross profit | 99.48 | -11.48 |
EBIT | 99.48 | -11.48 |
Net earnings | 76.07 | -10.41 |
Shareholders equity total | 116.07 | 105.66 |
Balance sheet total (assets) | 204.50 | 142.98 |
Net debt | - 177.34 | - 113.37 |
Profitability | ||
EBIT-% | ||
ROA | 48.6 % | -6.6 % |
ROE | 65.5 % | -9.4 % |
ROI | 69.5 % | -8.3 % |
Economic value added (EVA) | 76.07 | -4.84 |
Solvency | ||
Equity ratio | 56.8 % | 73.9 % |
Gearing | 23.4 % | 25.7 % |
Relative net indebtedness % | ||
Liquidity | ||
Quick ratio | 2.3 | 3.8 |
Current ratio | 2.3 | 3.8 |
Cash and cash equivalents | 204.50 | 140.52 |
Capital use efficiency | ||
Trade debtors turnover (days) | ||
Net working capital % | ||
Credit risk | ||
Credit rating | B | C |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.